Progesterone
DrugBank ID: DB00396
Summary
| Metric | Value |
|---|---|
| Total Predictions | 53 |
| KG+DL (Dual Validated) | 5 |
| DL Only | 45 |
| KG Only | 3 |
Predictions
| Indication | Score | Source |
|---|---|---|
| amenorrhea (disease) | 1.0000 | DL |
| breast fibrocystic disease | 0.9998 | DL |
| endometriosis of uterus | 0.9998 | DL |
| benign mammary dysplasia | 0.9998 | DL |
| renal hypoplasia, bilateral | 0.9997 | DL |
| cervix endometriosis | 0.9997 | DL |
| renal hypoplasia (disease) | 0.9997 | DL |
| endometriosis in cutaneous scar | 0.9997 | DL |
| endometriosis of rectovaginal septum and vagina | 0.9997 | DL |
| apocrine adenosis of breast | 0.9996 | DL |
| blunt duct adenosis of breast | 0.9996 | DL |
| gelatinous drop-like corneal dystrophy | 0.9995 | DL |
| infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly | 0.9995 | DL |
| breast abscess | 0.9994 | DL |
| fat necrosis of breast | 0.9994 | DL |
| lactation disease | 0.9993 | DL |
| breast adenosis | 0.9992 | DL |
| ovarian endometriosis | 0.9986 | DL |
| endometrial cancer | 0.9979 | KG+DL |
| endometrial carcinoma (disease) | 0.9976 | KG+DL |
| uterine corpus cancer | 0.9969 | KG+DL |
| caudal duplication | 0.9959 | DL |
| placenta cancer | 0.9955 | DL |
| hyperplastic polyposis syndrome | 0.9946 | DL |
| uterine corpus adenocarcinofibroma | 0.9942 | DL |
| uterine corpus adenosarcoma | 0.9942 | DL |
| sessile serrated polyposis cancer syndrome | 0.9941 | DL |
| uterine corpus choriocarcinoma | 0.9940 | DL |
| uterine carcinosarcoma | 0.9940 | DL |
| uterine corpus endometrial carcinoma | 0.9938 | DL |
| endometriosis (disease) | 0.9937 | KG+DL |
| colorectal cancer, hereditary nonpolyposis, | 0.9936 | DL |
| endometrial transitional cell carcinoma | 0.9935 | DL |
| endometrium neoplasm | 0.9934 | KG+DL |
| rare variants of adenocarcinoma of the corpus uteri | 0.9930 | DL |
| megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome | 0.9928 | DL |
| uterine corpus carcinofibroma | 0.9927 | DL |
| primitive neuroectodermal tumor of the corpus uteri | 0.9926 | DL |
| Muir-Torre syndrome | 0.9926 | DL |
| uterine corpus mixed epithelial and mesenchymal neoplasm | 0.9926 | DL |
| endometrioid stromal sarcoma | 0.9925 | DL |
| high-grade neuroendocrine carcinoma of the corpus uteri | 0.9923 | DL |
| congenital stromal corneal dystrophy | 0.9923 | DL |
| papillary carcinoma of the corpus uteri | 0.9920 | DL |
| adenoid cystic carcinoma of the corpus uteri | 0.9916 | DL |
| malignant germ cell tumor of corpus uteri | 0.9914 | DL |
| transitional cell carcinoma of the corpus uteri | 0.9914 | DL |
| low-grade neuroendocrine tumor of the corpus uteri | 0.9908 | DL |
| endometrium carcinoma in situ | 0.9903 | DL |
| tamoxifen-related endometrial lesion | 0.9840 | DL |
Showing top 50 of 53 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.